Injection-free dermally delivered subunit vaccine strongly neutralizes SARS-CoV-2 variants
Researchers in Australia have evaluated the vaccine candidature of HexaPro S protein subunit vaccine against SARS-CoV-2.
Source: news-medical.net
Fast, Ad-Free News Updates
Stay updated with breaking news from Dermal Delivery. Real-time updates on events, politics, business and more.